AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28142387 — intervention group
Group type: COMPARATOR
Intervention: Traditional vocational program
Number of subjects: 85
Study 26694748 — intervention group
Group type: EXPERIMENTAL
Intervention: Support by specialized oncology nurses for eight weeks after discharge from hospital by telephone, consisting of symptom monitoring, counselling on self-assessment and self-management, and dealing with individual resources for coping and psychosocial well-being.
Number of subjects: 370
Study 26694748 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 370
Study 23228922 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy (BB)
Number of subjects: 5628
Study 23228922 — intervention group
Group type: COMPARATOR
Intervention: No beta-blocker therapy
Number of subjects: 5628
Study 23228922 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy (BB) in high-risk patients (GRACE risk scores ≥121)
Number of subjects: 5628
Study 23228922 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy (BB) in high-risk patients (administered diuretics)
Number of subjects: 5628
Study 23228922 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy (BB) in lower risk patients
Number of subjects: 5628
Study 20830695 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 sessions with trauma narrative (TN)
Number of subjects: 210
Study 20830695 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 sessions without TN
Number of subjects: 210
Study 20830695 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 sessions with TN
Number of subjects: 210
Study 20830695 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 sessions without TN
Number of subjects: 210
Study 17761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 325
Study 17761505 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 325
Study 17761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES) with ISA
Number of subjects: 325
Study 17761505 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES) without ISA
Number of subjects: 325
Study 16416305 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ) with 0.25 mg triazolam
Number of subjects: 9
Study 16416305 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ) with 15 mg quazepam
Number of subjects: 9
Study 16416305 — intervention group
Group type: COMPARATOR
Intervention: Control (0.25 mg triazolam without GFJ)
Number of subjects: 9
Study 16416305 — intervention group
Group type: COMPARATOR
Intervention: Control (15 mg quazepam without GFJ)
Number of subjects: 9
Study 15018412 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic scalpel
Number of subjects: 30
Study 15018412 — intervention group
Group type: COMPARATOR
Intervention: Conventional instruments
Number of subjects: 30
Study 11188859 — intervention group
Group type: EXPERIMENTAL
Intervention: New randomized ablation pattern (OS)
Number of subjects: 16
Study 11188859 — intervention group
Group type: COMPARATOR
Intervention: Older sequential pattern (OS)
Number of subjects: 16
Study 11188859 — intervention group
Group type: EXPERIMENTAL
Intervention: New randomized ablation pattern (OD)
Number of subjects: 16
Study 11188859 — intervention group
Group type: EXPERIMENTAL
Intervention: Both patterns (OD and OS)
Number of subjects: 16
Study 8847321 — intervention group
Group type: EXPERIMENTAL
Intervention: New noninvasive blood pressure measurement method
Number of subjects: 26
Study 8847321 — intervention group
Group type: COMPARATOR
Intervention: Sphygmomanometry
Number of subjects: 26
Study 1556276 — intervention group
Group type: EXPERIMENTAL
Intervention: relaxation plus coping self-efficacy (SE) enhancement
Number of subjects: 48
Study 1556276 — intervention group
Group type: COMPARATOR
Intervention: relaxation only
Number of subjects: 48
Study 1556276 — intervention group
Group type: COMPARATOR
Intervention: procedural information
Number of subjects: 48
Study 1556276 — intervention group
Group type: COMPARATOR
Intervention: no preparation
Number of subjects: 48
Study 4029406 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for glottic T1N0 tumours
Number of subjects: 900
Study 4029406 — intervention group
Group type: EXPERIMENTAL
Intervention: Supra-glottic laryngectomy and prophylactic neck dissection for supra-glottic T1N0 tumours (first 7 years)
Number of subjects: 900
Study 4029406 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for supra-glottic T1N0 tumours (after first 7 years)
Number of subjects: 900
Study 4029406 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage surgery for failed radiotherapy or surgery for supra-glottic carcinoma
Number of subjects: 900
Study 31937103 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (Mediterranean and low-fat)
Number of subjects: 0
Study 31937103 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial glucagon levels
Number of subjects: 0
Study 31046695 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care viral load monitoring
Number of subjects: 794
Study 31046695 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care viral load monitoring
Number of subjects: 794
Study 30121304 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (n=10)
Number of subjects: 21
Study 30121304 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (n=11)
Number of subjects: 21
Study 30121304 — intervention group
Group type: COMPARATOR
Intervention: Both aerobic and resistance training
Number of subjects: 21
Study 26943948 — intervention group
Group type: EXPERIMENTAL
Intervention: HOBSCOTCH program with additional working memory training (H+)
Number of subjects: 66
Study 26943948 — intervention group
Group type: EXPERIMENTAL
Intervention: HOBSCOTCH program without additional working memory training (H)
Number of subjects: 66
Study 26943948 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 66
Study 26943948 — intervention group
Group type: EXPERIMENTAL
Intervention: HOBSCOTCH program (H+ and H)
Number of subjects: 66
Study 23678929 — intervention group
Group type: EXPERIMENTAL
Intervention: Jobs First welfare reform program
Number of subjects: 4612
Study 23678929 — intervention group
Group type: COMPARATOR
Intervention: Traditional welfare (Aid to Families with Dependent Children)
Number of subjects: 4612
Study 22297271 — intervention group
Group type: EXPERIMENTAL
Intervention: tramadol+dexamethasone
Number of subjects: 30
Study 22297271 — intervention group
Group type: COMPARATOR
Intervention: tramadol+diclofenac sodium
Number of subjects: 30
Study 19345072 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine (30 mg/day)
Number of subjects: 61
Study 19345072 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day)
Number of subjects: 61
Study 19345072 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of mirtazapine and paroxetine
Number of subjects: 61
Study 19345072 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 61
Study 19345072 — intervention group
Group type: COMPARATOR
Intervention: Non-responders on monotherapy
Number of subjects: 61
Study 17762217 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subgallate/borneol (Suile)
Number of subjects: 20
Study 17762217 — intervention group
Group type: COMPARATOR
Intervention: Bacitracin (control)
Number of subjects: 20
Study 15722985 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral polybacterial lysate suspension
Number of subjects: 83
Study 15722985 — intervention group
Group type: COMPARATOR
Intervention: No-treatment clinical follow-up (control group)
Number of subjects: 83
Study 12069142 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol 400 micrograms (two tablets of 200 micrograms each)
Number of subjects: 54
Study 12069142 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two tablets of vaginal placebo)
Number of subjects: 54
Study 10412244 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated polyglactin 910 (IRPG) Vicryl Rapide sutures
Number of subjects: 113
Study 10412244 — intervention group
Group type: COMPARATOR
Intervention: Polytetrafluoroethylene (PTFE) sutures
Number of subjects: 113
Study 10412244 — intervention group
Group type: COMPARATOR
Intervention: Traditional polyglycolic acid (PGLA) sutures
Number of subjects: 113
Study 10412244 — intervention group
Group type: COMPARATOR
Intervention: Skin staples
Number of subjects: 113
Study 7671893 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma ANP analysis
Number of subjects: 31
Study 2073911 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0
Study 2073911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7241106 — intervention group
Group type: EXPERIMENTAL
Intervention: Superimposed slide presentation
Number of subjects: 43
Study 7241106 — intervention group
Group type: COMPARATOR
Intervention: Separated slide presentation (control)
Number of subjects: 43
Study 6742393 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline approach
Number of subjects: 0
Study 6742393 — intervention group
Group type: EXPERIMENTAL
Intervention: Paramedian approach
Number of subjects: 0
Study 6742393 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 28715272 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-Face Behavioral Parent Training (F2F)
Number of subjects: 47
Study 28715272 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Behavioral Parent Training (Online BPT)
Number of subjects: 47
Study 28715272 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 47
Study 27672029 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentolinium (nicotinic ganglion blocker)
Number of subjects: 368
Study 27672029 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise
Number of subjects: 368
Study 27672029 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 368
Study 25080920 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical care ventilator with pressure‐synchronized intermittent mandatory ventilation (P‐SIMV) + PSV + PEEP (Group C)
Number of subjects: 63
Study 25080920 — intervention group
Group type: COMPARATOR
Intervention: Critical care ventilator with pressure support ventilation and positive end expiratory pressure (PSV + PEEP; Group B)
Number of subjects: 63
Study 25080920 — intervention group
Group type: COMPARATOR
Intervention: Miniventilator with BiLevel positive airway pressure (BiPAP; Group A)
Number of subjects: 63
Study 22337287 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN2a (90 mcg escalating to 180 mcg weekly for 48 weeks)
Number of subjects: 40
Study 22337287 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical care (no further antiviral therapy)
Number of subjects: 40
Study 20236841 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein collar
Number of subjects: 352
Study 20236841 — intervention group
Group type: COMPARATOR
Intervention: No vein collar
Number of subjects: 352
Study 18713253 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 0
Study 18713253 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study 18713253 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib + Dexamethasone +/− Erythropoietin
Number of subjects: 0
Study 15785283 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 24
Study 15785283 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 24
Study 11896977 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical repifermin (recombinant human keratinocyte growth factor-2) applied for 12 weeks
Number of subjects: 94
Study 11896977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 9448627 — intervention group
Group type: EXPERIMENTAL
Intervention: Open haemorrhoidectomy
Number of subjects: 67
Study 9448627 — intervention group
Group type: COMPARATOR
Intervention: Closed haemorrhoidectomy
Number of subjects: 67
Study 8305264 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex Doppler sonography (DDS)
Number of subjects: 22
Study 8305264 — intervention group
Group type: COMPARATOR
Intervention: Angiography
Number of subjects: 22
Study 2851877 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg/day ganciclovir
Number of subjects: 11
Study 2851877 — intervention group
Group type: COMPARATOR
Intervention: 10 mg/kg/day ganciclovir
Number of subjects: 11
Study 31630398 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide (50:50 mix with oxygen)
Number of subjects: 150
Study 31630398 — intervention group
Group type: COMPARATOR
Intervention: Medical air
Number of subjects: 150
Study 31630398 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide (50:50 mix with oxygen) among parous women
Number of subjects: 150
Study 31630398 — intervention group
Group type: COMPARATOR
Intervention: Medical air among parous women
Number of subjects: 150
Study 30136589 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) for 2 weeks postoperatively
Number of subjects: 68
Study 30136589 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative physiotherapy (breathing exercises, coughing techniques, early mobilization)
Number of subjects: 68
Study 26831892 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 94
Study 26831892 — intervention group
Group type: COMPARATOR
Intervention: Standard low fat diet
Number of subjects: 94
Study 24532260 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract (PE) consumers (900 mg/day for 15 days)
Number of subjects: 52
Study 24532260 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract (PE-1)
Number of subjects: 52
Study 24532260 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract (PE-2)
Number of subjects: 52
Study 24532260 — intervention group
Group type: EXPERIMENTAL
Intervention: Urolithin A or isourolithin A
Number of subjects: 52
Study 23110382 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report measures covering general health, self-management, emotional well-being, and contact with health care providers
Number of subjects: 3960
Study 23110382 — intervention group
Group type: EXPERIMENTAL
Intervention: Five complementary modules allocated randomly to participants
Number of subjects: 3960
Study 19493959 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine treatment for 8 weeks
Number of subjects: 243
Study 17535542 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 10
Study 16108399 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO) plus iron supplementation for ten days before surgery and five days postoperatively
Number of subjects: 38
Study 16108399 — intervention group
Group type: COMPARATOR
Intervention: Iron supplementation only
Number of subjects: 38
Study 12086353 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate and calcium
Number of subjects: 150
Study 12086353 — intervention group
Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 150
Study 9815866 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 250 mg and Ticlopidine 500 mg/d (A+T group)
Number of subjects: 350
Study 9815866 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 250 mg/d and oral anticoagulation (A+OAC group)
Number of subjects: 350
Study 8596098 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 129
Study 8596098 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 129
Study 8596098 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 129
Study 2698587 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodilution with repeated venesections (total 250-1000 ml) and concomitant dextran 40 administration
Number of subjects: 485
Study 2698587 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hemodilution)
Number of subjects: 485
Study 2698587 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodilution
Number of subjects: 485
Study 1124532 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral delta‐1‐(trans)‐tetrahydrocannabinol
Number of subjects: 16
Study 1124532 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 16
Study 1124532 — intervention group
Group type: EXPERIMENTAL
Intervention: oral delta‐1‐(trans)‐tetrahydrocannabinol
Number of subjects: 16
Study 1124532 — intervention group
Group type: EXPERIMENTAL
Intervention: delta‐1‐(trans)‐tetrahydrocannabinol
Number of subjects: 16
Study 31658381 — intervention group
Group type: EXPERIMENTAL
Intervention: AJM300 960 mg
Number of subjects: 23
Study 31658381 — intervention group
Group type: EXPERIMENTAL
Intervention: AJM300 240 mg
Number of subjects: 23
Study 31658381 — intervention group
Group type: EXPERIMENTAL
Intervention: AJM300 480 mg
Number of subjects: 23
Study 31658381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 30691468 — intervention group
Group type: EXPERIMENTAL
Intervention: Umeclidinium bromide/vilanterol 62.5/25 mcg
Number of subjects: 0
Study 30691468 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium/olodaterol 5/5 mcg
Number of subjects: 0
Study 29544572 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin alone
Number of subjects: 108
Study 29544572 — intervention group
Group type: COMPARATOR
Intervention: Metformin plus Simvastatin
Number of subjects: 108
Study 26388147 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (acute, subanaesthetic doses)
Number of subjects: 0
Study 26388147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26388147 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study 24629823 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1 μg/kg
Number of subjects: 100
Study 24629823 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 100
Study 22079151 — intervention group
Group type: EXPERIMENTAL
Intervention: Augment strategy (n=269)
Number of subjects: 538
Study 22079151 — intervention group
Group type: COMPARATOR
Intervention: Switch strategy (n=269)
Number of subjects: 538
Study 18166179 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/d for 5 days starting on day 3 of menses; 115 patients, 243 cycles)
Number of subjects: 216
Study 18166179 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC; 100 mg/d; 101 patients, 226 cycles)
Number of subjects: 216
Study 17785984 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-stitch purse-string suture
Number of subjects: 90
Study 17785984 — intervention group
Group type: COMPARATOR
Intervention: 6-stitch purse-string suture
Number of subjects: 90
Study 14981835 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose helical CT with 10 mm collimation
Number of subjects: 40
Study 14981835 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose helical CT with 8 mm collimation
Number of subjects: 40
Study 14981835 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose helical CT with 5 mm collimation
Number of subjects: 40
Study 14981835 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential subsection scan of chest with 50 mA and 8 mm collimation
Number of subjects: 40
Study 12476289 — intervention group
Group type: EXPERIMENTAL
Intervention: ganciclovir
Number of subjects: 91
Study 12476289 — intervention group
Group type: COMPARATOR
Intervention: acyclovir
Number of subjects: 91
Study 10099946 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining group (stop normal training but continue activities of daily living)
Number of subjects: 16
Study 10099946 — intervention group
Group type: COMPARATOR
Intervention: Control group (continue normal training)
Number of subjects: 16
Study 10099946 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining group
Number of subjects: 16
Study 10099946 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining group and Control group
Number of subjects: 16
Study 7546784 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography
Number of subjects: 46
Study 7546784 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole stress echocardiography
Number of subjects: 46
Study 7546784 — intervention group
Group type: COMPARATOR
Intervention: Both dobutamine and dipyridamole stress echocardiography
Number of subjects: 46
Study 1971751 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 50
Study 1971751 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 50
Study 698606 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulant group
Number of subjects: 68
Study 698606 — intervention group
Group type: COMPARATOR
Intervention: Recumbent group
Number of subjects: 68
Study 31864166 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory-control training to cocaine images
Number of subjects: 40
Study 31864166 — intervention group
Group type: COMPARATOR
Intervention: Neutral image training
Number of subjects: 40
Study 30927159 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg PEA
Number of subjects: 111
Study 30927159 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg PEA
Number of subjects: 111
Study 30927159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 27862837 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 230
Study 27862837 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecture
Number of subjects: 230
Study 27862837 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 230
Study 26354213 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem Cell Therapy (SCT) - infusion of 5-10 × 10^8 autologous mononuclear cells (MNC) by intra-coronary route
Number of subjects: 250
Study 26354213 — intervention group
Group type: COMPARATOR
Intervention: Standard Medical Therapy (non SCT group)
Number of subjects: 250
Study 26354213 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem Cell Therapy (SCT) with cell dose ≥ 5 × 10^8 (n=71)
Number of subjects: 250
Study 23932151 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal mycosis (OPM) cases during radiotherapy
Number of subjects: 410
Study 20346621 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pass filter cutoff frequency of 300 Hz or higher
Number of subjects: 0